163 related articles for article (PubMed ID: 21332419)
1. Topical nonnucleoside reverse transcriptase inhibitor MC 1220 partially prevents vaginal RT-SHIV infection of macaques.
Stolte-Leeb N; Loddo R; Antimisiaris S; Schultheiss T; Sauermann U; Franz M; Mourtas S; Parsy C; Storer R; La Colla P; Stahl-Hennig C
AIDS Res Hum Retroviruses; 2011 Sep; 27(9):933-43. PubMed ID: 21332419
[TBL] [Abstract][Full Text] [Related]
2. Characterization of vaginal transmission of a simian human immunodeficiency virus (SHIV) encoding the reverse transcriptase gene from HIV-1 in Chinese rhesus macaques.
Pal R; Nuttall J; Galmin L; Weiss D; Chung HK; Romano J
Virology; 2009 Mar; 386(1):102-8. PubMed ID: 19195672
[TBL] [Abstract][Full Text] [Related]
3. In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques.
Ambrose Z; Boltz V; Palmer S; Coffin JM; Hughes SH; Kewalramani VN
J Virol; 2004 Dec; 78(24):13553-61. PubMed ID: 15564466
[TBL] [Abstract][Full Text] [Related]
4. The nonnucleoside reverse transcriptase inhibitor MIV-150 in carrageenan gel prevents rectal transmission of simian/human immunodeficiency virus infection in macaques.
Singer R; Derby N; Rodriguez A; Kizima L; Kenney J; Aravantinou M; Chudolij A; Gettie A; Blanchard J; Lifson JD; Piatak M; Fernández-Romero JA; Zydowsky TM; Robbiani M
J Virol; 2011 Jun; 85(11):5504-12. PubMed ID: 21411526
[TBL] [Abstract][Full Text] [Related]
5. MIV-150/zinc acetate gel inhibits cell-associated simian-human immunodeficiency virus reverse transcriptase infection in a macaque vaginal explant model.
Barnable P; Calenda G; Bonnaire T; Menon R; Levendosky K; Gettie A; Blanchard J; Cooney ML; Fernández-Romero JA; Zydowsky TM; Teleshova N
Antimicrob Agents Chemother; 2015 Jul; 59(7):3829-37. PubMed ID: 25870063
[TBL] [Abstract][Full Text] [Related]
6. Generation of a dual RT Env SHIV that is infectious in rhesus macaques.
Smith JM; Dauner A; Li B; Srinivasan P; Mitchell J; Hendry M; Ellenberger D; Butera S; Otten RA
J Med Primatol; 2010 Aug; 39(4):213-23. PubMed ID: 20618587
[TBL] [Abstract][Full Text] [Related]
7. Repetitive exposures with simian/human immunodeficiency viruses: strategy to study HIV pre-clinical interventions in non-human primates.
Kim CN; Adams DR; Bashirian S; Butera S; Folks TM; Otten RA
J Med Primatol; 2006 Aug; 35(4-5):210-6. PubMed ID: 16872284
[TBL] [Abstract][Full Text] [Related]
8. Efavirenz therapy in rhesus macaques infected with a chimera of simian immunodeficiency virus containing reverse transcriptase from human immunodeficiency virus type 1.
Hofman MJ; Higgins J; Matthews TB; Pedersen NC; Tan C; Schinazi RF; North TW
Antimicrob Agents Chemother; 2004 Sep; 48(9):3483-90. PubMed ID: 15328115
[TBL] [Abstract][Full Text] [Related]
9. A combination microbicide gel protects macaques against vaginal simian human immunodeficiency virus-reverse transcriptase infection, but only partially reduces herpes simplex virus-2 infection after a single high-dose cochallenge.
Hsu M; Aravantinou M; Menon R; Seidor S; Goldman D; Kenney J; Derby N; Gettie A; Blanchard J; Piatak M; Lifson JD; Fernández-Romero JA; Zydowsky TM; Robbiani M
AIDS Res Hum Retroviruses; 2014 Feb; 30(2):174-83. PubMed ID: 24117013
[TBL] [Abstract][Full Text] [Related]
10. Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5.
Lederman MM; Veazey RS; Offord R; Mosier DE; Dufour J; Mefford M; Piatak M; Lifson JD; Salkowitz JR; Rodriguez B; Blauvelt A; Hartley O
Science; 2004 Oct; 306(5695):485-7. PubMed ID: 15486300
[TBL] [Abstract][Full Text] [Related]
11. Protective properties of non-nucleoside reverse transcriptase inhibitor (MC1220) incorporated into liposome against intravaginal challenge of Rhesus macaques with RT-SHIV.
Caron M; Besson G; Etenna SL; Mintsa-Ndong A; Mourtas S; Radaelli A; Morghen Cde G; Loddo R; La Colla P; Antimisiaris SG; Kazanji M
Virology; 2010 Sep; 405(1):225-33. PubMed ID: 20591460
[TBL] [Abstract][Full Text] [Related]
12. Exposure to MIV-150 from a high-dose intravaginal ring results in limited emergence of drug resistance mutations in SHIV-RT infected rhesus macaques.
Hsu M; Keele BF; Aravantinou M; Krawczyk N; Seidor S; Abraham CJ; Zhang S; Rodriguez A; Kizima L; Derby N; Jean-Pierre N; Mizenina O; Gettie A; Grasperge B; Blanchard J; Piatak MJ; Lifson JD; Fernández-Romero JA; Zydowsky TM; Robbiani M
PLoS One; 2014; 9(2):e89300. PubMed ID: 24586674
[TBL] [Abstract][Full Text] [Related]
13. Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel.
Cranage M; Sharpe S; Herrera C; Cope A; Dennis M; Berry N; Ham C; Heeney J; Rezk N; Kashuba A; Anton P; McGowan I; Shattock R
PLoS Med; 2008 Aug; 5(8):e157; discussion e157. PubMed ID: 18684007
[TBL] [Abstract][Full Text] [Related]
14. Virological and molecular characterization of a simian human immunodeficiency virus (SHIV) encoding the envelope and reverse transcriptase genes from HIV-1.
Pal R; Galmin L; Pereira LE; Li B; Zhang J; Li D; Francis J; McNicholl JM; Weiss DE; Smith JM
Virology; 2012 Oct; 432(1):173-83. PubMed ID: 22769870
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of topical tenofovir against transmission of a tenofovir-resistant SHIV in macaques.
Dobard CW; Sharma S; Cong ME; West R; Makarova N; Holder A; Pau CP; Hanson DL; Novembre FJ; Garcia-Lerma JG; Heneine W
Retrovirology; 2015 Aug; 12():69. PubMed ID: 26253002
[TBL] [Abstract][Full Text] [Related]
16. Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion.
Veazey RS; Klasse PJ; Schader SM; Hu Q; Ketas TJ; Lu M; Marx PA; Dufour J; Colonno RJ; Shattock RJ; Springer MS; Moore JP
Nature; 2005 Nov; 438(7064):99-102. PubMed ID: 16258536
[TBL] [Abstract][Full Text] [Related]
17. Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques.
Miyake A; Akagi T; Enose Y; Ueno M; Kawamura M; Horiuchi R; Hiraishi K; Adachi M; Serizawa T; Narayan O; Akashi M; Baba M; Hayami M
J Med Virol; 2004 Jul; 73(3):368-77. PubMed ID: 15170630
[TBL] [Abstract][Full Text] [Related]
18. Suppression of acute viremia by short-term postexposure prophylaxis of simian/human immunodeficiency virus SHIV-RT-infected monkeys with a novel reverse transcriptase inhibitor (GW420867) allows for development of potent antiviral immune responses resulting in efficient containment of infection.
Mori K; Yasutomi Y; Sawada S; Villinger F; Sugama K; Rosenwith B; Heeney JL; Uberla K; Yamazaki S; Ansari AA; Rübsamen-Waigmann H
J Virol; 2000 Jul; 74(13):5747-53. PubMed ID: 10846052
[TBL] [Abstract][Full Text] [Related]
19. The nonnucleoside reverse transcription inhibitor MIV-160 delivered from an intravaginal ring, but not from a carrageenan gel, protects against simian/human immunodeficiency virus-RT Infection.
Aravantinou M; Singer R; Derby N; Calenda G; Mawson P; Abraham CJ; Menon R; Seidor S; Goldman D; Kenney J; Villegas G; Gettie A; Blanchard J; Lifson JD; Piatak M; Fernández-Romero JA; Zydowsky TM; Teleshova N; Robbiani M
AIDS Res Hum Retroviruses; 2012 Nov; 28(11):1467-75. PubMed ID: 22816564
[TBL] [Abstract][Full Text] [Related]
20. SIV/HIV Nef recombinant virus (SHIVnef) produces simian AIDS in rhesus macaques.
Mandell CP; Reyes RA; Cho K; Sawai ET; Fang AL; Schmidt KA; Luciw PA
Virology; 1999 Dec; 265(2):235-51. PubMed ID: 10600596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
